Ivabradine hydrochloride
Post Date: |
Jul 06,2015 |
Expiry Date: |
Jul 05,2016 |
Detailed Description: |
Cas No. :148849-67-6
Specs:98%,99%
Ivabradine hydrochloride is indicated for the symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm who cannot take beta blockers. It is also indicated in combination with beta blockers in patients inadequately controlled by beta blockers alone and whose heart rate exceeds 70 beats per minute.
It has been shown to be as effective as the beta blocker atenolol and comparable with amlodipine in the management of chronic stable angina |
CAS Registry Number: |
|
Synonyms: |
;Ivabradine HCl;3-[3-[[(8S)-3,4-Dimethoxy-8-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride;3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one Hydrochloride;3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride; |
Molecular Formula: |
C27H37ClN2O5 |
Molecular Weight: |
505.0461 |
Molecular Structure: |
|
Company: |
Jiangsu Yutian pharmaceutical company Co.,ltd
[ China ]
|
Contact: |
Wendy |
Tel: |
+86-518-86098000 |
Fax: |
+86-518-86098001 |
Email: |
wdcui@jsytsw.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.